Quantum BioPharma FY2025 opposes CIBC and RBC motion to dismiss; cash and digital assets total $11 million USD

Quantum Biopharma Ltd. Subordinate Voting Shares Class B
Royal Bank of Canada
Canadian Imperial Bank of Commerce

Quantum Biopharma Ltd. Subordinate Voting Shares Class B

QNTM

0.00

Royal Bank of Canada

RY

0.00

Canadian Imperial Bank of Commerce

CM

0.00
  • Quantum said it filed a Memorandum of Law opposing a joint motion to dismiss by CIBC World Markets and RBC Dominion Securities in a lawsuit alleging stock market manipulation.
  • The company said the case is pending a ruling in the US District Court for the Southern District of New York.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603270810PRIMZONEFULLFEED9679519) on March 27, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.